Yeonsue Jang

Yeonsue Jang

Auto-generated profile, based on publicly available information

Yeonsue Jang

Department of Pathology, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Acta Biomaterialia
Verified
Journal Article
Closed access
DYDong Suk Yoon
Dong Suk Yoon
YLYunki Lee
Yunki Lee
HRHyun Aae Ryu
Hyun Aae Ryu
YJYeonsue Jang
Yeonsue Jang
KLKyoung-Mi Lee
Kyoung-Mi Lee
JLJin Woo Lee
Jin Woo Lee

18 September 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
JSJin Sol Sung
Jin Sol Sung
CKChan Woo Kang
Chan Woo Kang
SKSuki Kang
Suki Kang
YJYeonsue Jang
Yeonsue Jang
YCYoung Chan Chae
Young Chan Chae
NCNamhoon Cho
Namhoon Cho

7 August 2014 in Stem Cells
Verified
Journal Article
Open access
PDF file
DYDong Suk Yoon
Dong Suk Yoon
YCYoorim Choi
Yoorim Choi
YJYeonsue Jang
Yeonsue Jang
MLMoses Lee
Moses Lee
WCWoo Jin Choi
Woo Jin Choi
JLJin Woo Lee
Jin Woo Lee
SOX2 is crucial for the maintenance of the self-renewal capacity and multipotency of mesenchymal stem cells (MSCs); however, the mechanism by which SOX2 is regulated remains unclear. Here, we report that RNA interference of sirtuin 1 (SIRT1) in human bone marrow (BM)-derived MSCs leads to a decrease of SOX2 protein, resulting in the deterioration of the self-renewal and differentiation capacities of BM-MSCs. Using immunoprecipitation, we demonstrated direct binding between SIRT1 and SOX2 in HeLa cells overexpressing SOX2. We further discovered that the RNA interference of SIRT1 induces the acetylation, nuclear export, and ubiquitination of SOX2, leading to proteasomal degradation in BM-MSCs. SOX2 suppression by trichostatin A (TSA), a known histone deacetylase inhibitor, was reverted by treatment with resveratrol (0.1 and 1 µM), a known activator of SIRT1 in BM-MSCs. Furthermore, 0.1 and 1 µM resveratrol reduced TSA-mediated acetylation and ubiquitination of SOX2 in BM-MSCs. SIRT1 activation by resveratrol enhanced the colony-forming ability and differentiation potential to osteogenic and adipogenic lineages in a dose-dependent manner. However, the enhancement of self-renewal and multipotency by resveratrol was significantly decreased to basal levels by RNA interference of SOX2. These results strongly suggest that the SIRT1-SOX2 axis plays an important role in maintaining the self-renewal capability and multipotency of BM-MSCs. In conclusion, our findings provide evidence for positive SOX2 regulation by post-translational modification in BM-MSCs through the inhibition of nuclear export and subsequent ubiquitination, and demonstrate that SIRT1-mediated deacetylation contributes to maintaining SOX2 protein in the nucleus. Stem Cells 2014;32:3219–3231

24 March 2014 in Stem Cells and Development
Verified
Journal Article
Closed access
SLSeulgi Lee
Seulgi Lee
DYDong Suk Yoon
Dong Suk Yoon
SPSeungil Paik
Seungil Paik
KLKyoung-Mi Lee
Kyoung-Mi Lee
YJYeonsue Jang
Yeonsue Jang
JLJin Woo Lee
Jin Woo Lee
The chondrogenic differentiation process of human mesenchymal stem cells (hMSCs) passes through multiple stages, which are carried out by various factors and their interactions. Recently, microRNAs that regulate chondrogenic differentiation have been reported. However, microRNA that regulates SRY-related high mobility group-box gene 9 (Sox9), a chondrogenic key factor, has not been identified in hMSC. In this study, we identified that microRNA-495 (miR-495) is an important regulator of hMSC chondrogenic differentiation. In our microarray, miR-495 was downregulated during transforming growth factor (TGF)-β3-induced chondrogenic differentiation of hMSCs in vitro. We found that there is an miR-495 binding site in the 3′ untranslated region (3′UTR) of Sox9 . We confirmed opposite expression between miR-495 and Sox9 by using real-time polymerase chain reaction. Further, overexpression of miR-495 inhibited Sox9 expression, and repression of miR-495 increased expression of Sox9 in SW1353 cells and hMSCs. Additionally, luciferase analysis revealed that miR-495 directly binds to the Sox9 3′UTR, and we confirmed a seed sequence of miR-495 on the Sox9 3′UTR. Subsequently, overexpression of miR-495 repressed the expression of the extracellular matrix (ECM) protein, such as type II collagen (Col2A1), aggrecan, and proteoglycan products, whereas inhibition of miR-495 increased their expression. Collectively, this study indicates that miR-495 directly targets Sox9, ultimately leading to the regulation of chondrogenic differentiation in hMSCs.

1 January 2020 in Cancer Letters
Verified
Journal Article
Closed access
JKJi Eun Kim
Ji Eun Kim
BKBaek Gil Kim
Baek Gil Kim
YJYeonsue Jang
Yeonsue Jang
SKSuki Kang
Suki Kang
JLJoo Hyun Lee
Joo Hyun Lee
NCNamhoon Cho
Namhoon Cho

1 November 2014 in In Vitro Cellular & Developmental Biology - Animal
Verified
Journal Article
Closed access
PDF file
YJYeonsue Jang
Yeonsue Jang
YKYong Gon Koh
Yong Gon Koh
YCYun-Jin Choi
Yun-Jin Choi
SKSung-Hwan Kim
Sung-Hwan Kim
DYDong Suk Yoon
Dong Suk Yoon
JLJin Woo Lee
Jin Woo Lee